Editorial

In Silico Recognition of Natural Products for Medical Care

Abstract

Natural products have been always using for several types of applications by humankind for so many years. Food and medical applications have been seen very much important for such products in their original forms or reproduction in new forms. As a main resource for generating so many other compounds, synthetic derivatives have been evaluated for the essential extractions of natural products for more specified applications especially for medical core with controlled dosage medication and compounds. Therefore, recognition of potency of natural products for such specified application have been always seen as a dominant factor for undergoing further improvements in this case. Besides the original extracted essentials, modifying chemical structures could help for lead optimization of such important compounds for possible efficient cares. Indeed, lead optimization could be provided very well by employing in silico approach for potent chemical compounds up to reaching them to specified medication.

1. de Souza Neto LR, Moreira-Filho JT, Neves BJ, Maidana RL, Guimarães AC, Furnham N, Andrade CH, Silva Jr FP. In silico strategies to support fragment-to-lead optimization in drug discovery. Front Chem 2020;8:93.
2. Mirzaei M. Making sense the ideas in silico. Lab-in-Silico 2020;1(2):31-32.
3. Zandi H, Harismah K. Computer-based tools for structural characterizations and activity specifications of natural products: a quick review. Lab-in-Silico. 2021;2(1):50-54.
4. Mirzaei M, Harismah K, Soleimani M, Mousavi S. Inhibitory effects of curcumin on aldose reductase and cyclooxygenase-2 enzymes. J Biomol Struct Dyn 2021:in press.
5. Mirzaei M. Science and engineering in silico. Adv J Sci Eng 2020;1(1):1-2.
6. Khalid H, Hussain R, Hafeez A. Virtual screening of Piperidine based small molecules against COVID-19. Lab-in-Silico. 2020;1(2):50-55.
7. Gupta MK, Vadde R. In silico identification of natural product inhibitors for γ‐secretase activating protein, a therapeutic target for Alzheimer's disease. J Cell Biochem 2019;120(6):10323-1036.
8. Durán-Iturbide NA, Díaz-Eufracio BI, Medina-Franco JL. In silico ADME/Tox profiling of natural products: a focus on Biofacquim. ACS Omega 2020;5(26):16076-16084.
9. Nazemi H, Mirzaei M, Jafari E. Antidepressant activity of curcumin by monoamine oxidase–A inhibition. Adv J Chem B 2019;1(1):3-9.
10. Harismah K, Mirzaei M. In silico interactions of steviol with monoamine oxidase enzymes. Lab-in-Silico. 2020;1(1):3-6.
Files
IssueVol 9 No 1 (2021): Winter 2021 QRcode
SectionEditorial
Published2021-04-04
DOI https://doi.org/10.18502/jpc.v9i1.6029
Keywords
Natural product In silico Drug design

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mirzaei M. In Silico Recognition of Natural Products for Medical Care. J Pharm Care. 9(1):1-2.